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2 Abstract 
Gastrointestinal parasites such as the nematode Haemonchus contortus and protozoa 
Coccidia pose a serious threat to the global goat industry due to resistance of parasites to 
anthelmintic drugs. The objective of this study was to evaluate the effect of extracts of CorPet 
biomass, a mushroom (Coriolus versicolor) on gastrointestinal parasite infection and innate 
immunity in goats. Fifteen female SpanishXBoer goats were drenched with 10 ml of either a hot 
extract of CorPet (N=5), a cold extract (N=5), or with sterile water (control N=5) for eight 
weeks. Treatment groups were reversed after four weeks. Body weight, body condition and 
FAMACHA scores, fecal and blood samples were collected weekly. Blood was used for white 
blood cell differential counts, packed cell volume and isolation of total RNA.  Fecal samples 
were used for microbial DNA isolation and enumeration of parasite eggs. The Nanodrop 
spectrophotometer was used to determine the concentration and purity of DNA and RNA. 
Neutrophils were isolated using differential centrifugation and hypotonic lysis of red cells from 
blood. RNA was isolated from neutrophils using Trizol and then converted to cDNA. The human 
Toll-like receptor signaling pathway array was used to profile the expression of 84 genes. Total 
plasma protein concentration was determined using the BCA assay and migration patterns on 
silver stained gels. Pro-inflammatory cytokine and Prostaglandin E2α secretion was determined 
by ELISA. Data were analyzed using SAS statistical analysis software (P<0.05). Mushrooms did 
not affect health indicators including fecal egg counts (p>0.05) and increased plasma proteins 
(p<0.001). Treatment decreased GMCSF and increased GCSF, and IFNr, secretion. Treatment 
modulated expression of goat neutrophil Toll-like receptor pathway genes. Eight TLR’s were 
expressed on goat neutrophils. The highest fold change was observed for TLR6 and TIRAP. 
Modulation of these genes using CV mushroom probiotics as an oral has implication for health.  
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CHAPTER 1 
Introduction 
Growth in population is increasing thereby increasing the demand in food. By the year 
2050, it is projected that the world population would be expected to reach 8.3 to 10.9 billion. 
This population growth has led to the increased demand of food. The world goat population has 
been on the increase during the last three decades and currently stands at almost 840 million 
herds (Simela et al., 2008). They predominate as the major livestock in the poorest parts of the 
world (Simela et al., 2008). To ensure that food does not become a privilege-commodity, 
scientists are exploring new approaches with sustainable resources and innovations within these 
essential agricultural sectors to accommodate for and stabilize supply in this era of a rising 
population (Godfray et al., 2010).  
Ruminant products contribute to one of the major sources of food and protein consumed 
worldwide. Production of small ruminant is a growing industry in the U.S due to stable ethnic 
markets (NASS, 2009), rapidly increasing demand for grass-fed, or organically produced 
livestock (Green et al., 2003), and the growing popularity of specialty meat type goat breeds 
(Joshi et al., 2011). Meat goats do not require much supplemental feed and complicated 
infrastructure to allocate the animals (Coffey, 2002). According to the United States Department 
of Agriculture and the National Agricultural Statistics Service, three million herds of goats were 
accounted for in the United States in the 2010 sheep and goat report. The recent increase in goat 
production also results from the rising demand by increase numbers of ethnic groups into the 
U.S. who favor goat meat and goat products (Engle et al., 2000). This new trend has brought 
about new opportunities to grow and sustain goat production in the U.S. (Nadarajah, 2010). 
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Goat production, however, is negatively affected by several factors: respiratory diseases 
such as pneumonia, pregnancy toxemia and feed toxicity, including infectious and parasitic 
diseases. Goats are vulnerable to viral and bacterial diseases, such as foot and mouth disease, and 
mastitis. Among the latter, gastrointestinal infection remains one of the main constraints to dairy 
goat production (Rinaldi et al., 2007). Gastrointestinal nematodes or parasites (GIN) are an 
important limiting factor in goat production systems globally, and especially in humid climates 
(Terrill et al., 2007). There are many parasites that cause an array of health problems in sheep 
and goat production, but none more significant than H. contortus and Coccidia Emiria spp 
(Miller et al., 2006). Due to overuse and incorrect application of anthelmintics to control 
parasitic infection, the results have been increases in anthelmintic resistance weakening many 
drug programs to control infection (Miller, 2000). However, as the anthelmintic resistance of 
parasites to available products is increasing the need for improvement on current procedures for 
their control becomes a priority (Thamsborgh et al., 1999). Introduction of breeding schemes for 
resistance (Mandonnet et al., 2001), improved farm management practices and employing the 
FAMACHA© system (Zajac, 2002) are many of the alternate approaches used. Plant based 
anthelmintics have also been explored for use in the elimination of GI nematodes. 
One potential alternative for control of GI nematode infection is to take advantage of the 
host’s immune response in selection programs to increase the level of resistance in the 
population. The innate immune system is the primary responder to non-specific pathogens and is 
governed by phagocytic dendritic cells and macrophages. The responsibilities of the innate 
immune system include the ability to differentiate between self (host) and foreign pathogens 
(Akira, 2006). For many years, probiotics have been known to confer health benefits and may 
have the ability to modulate immune responses. This research evaluates the effect of oral 
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administration of CorPet powder, a mushroom powder, of Coriolus versicolor on the immune 
response on goat. 
The findings of this study could possibly aid in the improvements of GI nematode control 
by identifying the genes involved in the innate immune response in goats. This study could also 
provide the knowledge of the effects of mushroom probiotics as an alternative for control of GI 
nematodes in goats to help improve strengthen GI nematode management practices in the United 
States meat goat industry as it continues to develop. 
The objective of this study was to evaluate the effect of extracts of CorPet on 
gastrointestinal parasite infection and innate immunity in goats. 
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4 CHAPTER 2  
Literature Review 
2.1 Goat Production  
 The world goat population has been on the increase during the last three decades and 
currently stands at almost 840 million herds (Simela et al., 2008). Goats are a critical resource 
for milk and meat in many parts of the world. They predominate as the major livestock in the 
poorest parts of the world (Simela et al., 2008). Production of small ruminant is a growing 
industry in the U.S due to stable ethnic markets (NASS, 2009), rapidly increasing demand for 
grass-fed or organically produced livestock (Green et al., 2003), and the growing popularity of 
specialty meat-type goat breeds (Joshi et al., 2011). Goat production is an important industry in 
southeastern United States because of availability of forages and a rising market demand 
particularly for organically produced meat (Robinson, 2004). It is an attractive enterprise for 
farmers due to the relatively low cost of breeding stock, a high reproductive rate, requirement of 
minimal capital input as compared to other livestock species, and the ability of small ruminants 
to thrive on native pasture or brush land that is unsuitable for cropping or grazing by cattle 
(Schiere et al., 2002). Meat goats do not require much supplemental feed and complicated 
infrastructure to allocate the animals (Coffey, 2002) and their sturdiness and small size allows 
them to adapt to different environments (Engle et al., 2000).  
The recent rise in goat production and products in the U.S. can be directly attributed to 
the effects of an expanding market aligned with the on-going increase in foreign-born ethnic 
groups migrating to the U.S. with a preference for goat meat and products (Solaiman, 2007). 
Additionally, goat meat is considered as lean meat and can be a beneficial meat-substitute for 
people seeking healthier diet alternatives (Solaiman, 2007). Due to the increased number of 
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consumers of goat products, growth in demand is projected to follow (Nadarajah, 2010). 
Although this new facet of agriculture is growing, it faces many challenges due to the lack of 
organization and structure in the goat market (Nadarajah, 2010). This growth still brings many 
opportunities to improve and sustain the goat market as the demand for goat meat and other 
byproducts increase. Improving selective genetic schemes and nutrition within marketed goat 
breeds will be an important factor to the growth and future of the United States goat industry, as 
structure is gained (Nadarajah, 2010).  
            2.1.1 Parasite Problem in Goat Production. Goats are a critical resource for milk and meat 
in many parts of the world, but are still susceptible to a number of diseases. Among the conditions 
affecting goats are internal parasites, respiratory diseases such as pneumonia, foot rot, pregnancy 
toxemia and feed toxicity. Goats are also susceptible to various viral and bacterial diseases, such 
as foot and mouth disease, pink eye, and mastitis. Parasitic infection is recognized worldwide as 
a limiting factor in the production of goats. Infection with internal parasites and gastrointestinal 
nematodes is a major threat to the health and productivity of small ruminants (sheep and goats) 
in the United States, particularly in recently-weaned kids and lambs (Bowan, 2009). 
Gastrointestinal (GI) nematode infections are common in grazing ruminants worldwide 
and still are one of the main constraints to ruminant production because they can depress food 
intake, tissue damage, reduction in skeletal growth and live-weight gain (Waller, 1997). 
Economic losses caused by GI nematodes are associated with decreased production and limited 
performance (Abebe et al., 2000). Combining knowledge of GI nematodes epizoology with 
modern anthelmintics has allowed great success on parasite control over the past decades. 
However, as the anthelmintic resistance of parasites to available products is increasing the need 
for improvement on current procedures for their control becomes a priority (Thamsborgh et al., 
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1999). The need for controlling GI nematodes is of great importance in small ruminant 
production.  
 Coccidiosis is a disease caused by a protozoa Eimeria spp which naturally occurs in soils 
is a major concern in young animals whose immune system has not matured (Kommuru et al., 
2014). The coccidia that are more pathogenic in goats are E. arloingi, E. christenseni, and E. 
ovinoidalis (Kahn et al., 2010). During weaning, goats encounter lowered immune function 
creating favorable conditions for an outbreak of coccidiosis that can rapidly spread in a herd of 
flock causing devastating consequences of diarrhea, dehydration, and even death (Bowan, 2009). 
The parasite causes harm to the host by destroying the mucosal lining of the abomasum depleting 
nutrient up-take, and leading to liver failure in dairy goats (Khan et al., 2010).  Coccidiosis is of 
great economic importance because of the losses due to clinical disease (diarrhea) and 
subclinical infections, as well as poor weight gain in particular (Chartier et al., 2011).  
In the United States and other countries around the world, Haemonchus contortus also 
known as the barber pole warm is the most important parasite from the strongylid nematodes.  H. 
contortus is one of the most prolific nematodes. According to Mortensen et al., 2003, H. 
contortus account for 75-100% of the total fecal nematode egg output which is a blood sucking 
parasite that thrives in warm climates.  Female H. contortus reach about three cm in length, 
making this species one of the largest of the strongylid nematodes of ruminants (Elsheikha et al., 
2011). A female worm may produce thousands of eggs each day and larvae on pastures can 
accumulate rapidly during the grazing season in regions where this species predominates. The 
prepatent period (length of time elapsing between infection of the host and parasite maturity) 
of H. contortus is about 17 to 21 days (Levine, 1985). Adult worms are short lived surviving in 
the host for only a few months (Courtney et al., 1983).  H. contortus has great pathogenic 
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potential because fourth-stage larvae and adults feed on host blood. Consequently, its effects on a 
flock or herd are often insidious because routine observation of animals may not reveal the 
extent of infection and owners may not recognize that disease is present until deaths occur. With 
favorable conditions for the survival and growth of the ‘free-living’ stages of H. contortus, 
during the warmer months of the year throughout much of the southern and eastern United States 
(warm and moist) kids and lambs grazing with their mothers can acquire a significant GI 
nematode infection which then increase at weaning due to increase exposure to the infective third 
stage (L3) larvae and stress (Kommuru et al., 2014). The fourth and final stage (L4) of the H. 
contortus life cycle is the reproduction stage. After the larvae penetrate the abomasum (true 
stomach) there is molting for a fourth and a fifth time to transition into the adult phase. Males 
and females feeds off of the host blood in the abomasum and reproduce with the female laying 
5,000 to 10,000 eggs per day passing through the feces to the external environment (Zajac, 
2006). The total process of the H. contortus life cycle, from the L1 to the L4 stage, takes roughly 
three weeks (Luginbuhl, 2000). 
2.1.2 Life Cycle of Haemonchus contortus. The life cycle of parasites starts with adult 
females laying eggs while residing in the abomasum. The eggs when laid are oval in shape and 
pass out of the animal in feces. At 260C and 100% humidity, the eggs take fourteen to seventeen 
hours to hatch and develop into L1 larvae stage. L1 larvae develop on pasture into L2, L3 and 
following ingestion by ruminant host, into the L4 stages before reaching the adult stage. After 
copulation, the adult females start laying eggs eighteen days after an oral infection with L3 and 
can be fully gravid by day 33. The L3 is the infective larval stage in which the host inadvertently 
ingests the parasite and it develops into an adult in the abomasum where they feed on blood 
(Nikolaou, 2006). 
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2.2 Innate Immune System 
Goat production is negatively affected by several factors including infectious and 
parasitic diseases. Among the latter GI infection remains one of the main constraints to goat 
production (Rinaldi et al., 2007). 
The main function of the immune system is to distinguish its own cells and tissues from 
other external cells and tissues in order to protect against infestation. The immune system has 
various mechanisms to eliminate external agents which include inactivation, lysis, agglutination, 
precipitation, or phagocytosis of foreign cells (Kahn et al., 2010). The animal immune system is 
composed of two related functional elements: the innate immune system and the adaptive 
immune systems (Hoffmann et al., 1999). Both function in coordination to protect against 
invading microorganisms (Medzhitov et al., 2002). 
Innate immunity is the first line of defense against organisms; it acts in a non-specific 
way through anatomical barriers (skin, mucus membrane), secretions and other elements. The 
adaptive immune system is the second line of defense which responds slower than the innate 
immunity system. Innate immune defense plays a key role in affording protection (Siwicki et al., 
1994). Unlike the innate immune system, the adaptive immune system has the ability to 
“memorize” infectious agents allowing the adaptive immune system to serve as a rapid response 
system if pathological agents are encountered again (Medzhitov et al., 2002). The innate immune 
system consists of natural killer cells, T-cell and B-cell, basophils eosinophils, monocytes, 
macrophages and polymorphonuclear neutrophils. These cells are called white blood cells or 
leukocytes and are also divided into two groups based on their morphology, granulocytes and 
agranulocytes. Granulocytes include eosinophils, neutrophils and basophils and agranulocytes 
are lymphocytes (T and B cells) and macrophages (Kaplan et al., 2004).  
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A differential white blood cell count is an important tool used to provide clinical 
diagnosis, monitoring of disease and blood disorders (Houwen, 2001). This system quantifies 
and differentiates white blood cells at one particular time giving insight to infection and if 
treatments are working (Houwen, 2001). White blood cell differentiation counts can be 
accomplished manually or by automated electronic systems (Krapp et al., 2002). The white blood 
cell percentages are determined by the counting of the ratio and morphology differentiation of 
the first 100 white blood cells observed (Khan et al., 2010). 
Table 1. 
White Blood Cell Differential Count Normal Value for Goats in Percentage (%). Adapted from 
Khan and Line, 2010 
Neutrophils Lymphocytes  Basophils  Monocytes  Eosinophils  
30-48 50-70 0-1 0-8 1-8 
 
2.3 Diagnosis of Gastrointestinal Parasites 
The most common symptoms of goats experiencing parasitic burden depends heavily on 
the observation of clinical symptoms associated with parasitic infection especially with H. 
contortus and Coccidia. The major limitation is instituting a selective approach which identifies 
those animals requiring treatment.  Anemia is the most detrimental effect of H. contortus 
infection which leads to death. The most common symptoms include high fecal egg count (FEC), 
weight loss and diarrhea. Phenotypic criteria can be used to indirectly estimate resistance to 
parasites such as fecal egg counts, white blood cell differential count, FAMACHA, packed-cell 
volume or immunological traits (Dominik, 2005). The McMaster egg counting technique is used 
to determine the levels of parasitic burden. Goats infected with H. contortus with a FEC greater 
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than 1000 epg indicate heavy infection while 500 epg signifies mild infection (Taylor, 2010). 
Oocyte counts of 5000 per gram or more in feces of host suspected of coccidia infection is 
indicative of clinical infection (Schoenian, 2011). It is also very important to evaluate hematocrit 
levels periodically to diagnose parasitic infection (Miller, 2000). This method is effective in 
assessing anemia probably caused by parasitism in sheep and goats (Khan et al., 2010).  
The use of the FAMACHA© card system is a system that was developed in South Africa 
for the classification of animals into categories based on levels of anemia caused by 
gastrointestinal parasites (Reynecke et al., 2011). In this method, called FAMACHA©, the ocular 
mucous membranes of sheep and goats are classified by comparison with a laminated color chart 
bearing pictures of sheep conjunctivae classified into five categories ranging from the normal 
red, through pink to practically white in severe anemia. Since anemia is the primary pathologic 
effect from infection with H. contortus, this system can be an effective tool for identifying those 
animals that require treatment (Kaplan, 2004). The FAMACHA system is widely used and is 
accepted by sheep and goat producers in the southern U.S. (Burke et. al., 2007). 
 
Figure 1. FAMACHA Anemia Guide (Kaplan et al., 2004). 
2.4 Treatment  
One potential alternative for control of GI nematode infection is to take advantage of the 
host’s immune response in selection programs to increase the level of resistance in the 
population. Resilience is the ability to be productive despite infection.  The traditional treatment 
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for infection with GI nematodes in weaned animals is the use of anthelimintics. Control of GI 
infections in goats relies almost exclusively on multiple and regular dosing of anthelmintics 
(Rinaldi and Cringoli, 2012). All of the approved available anthelmintics for goats in the United 
States fall into one of three major drug groups: the benzimidazoles, the cholinergic agonists, and 
the macrocyclic lactones (Zajac, 2006). Only Decoquinate and Monensis are FDA approved for 
the prevention of coccidiosis, but no drugs are approved for treatment of coccidiosis in goats 
(Kommuru, 2014). Anthelmintics therefore are needed but current ones are ineffective due to 
anthelmintics resistance especially in the humid tropics, where the free-living stages of parasitic 
nematodes such as H. contortus (Kaplan, 2004) meet adequate climatic conditions to develop 
during almost the entire year (Mahieu et al., 2007).  
Since the advent in the 1960s of modern broad-spectrum anthelmintics with wide safety 
margins, producers have relied on dewormers for control of GI nematodes in the United States. 
In the southeastern United States where H. contortus causes substantial losses, frequent 
treatments were used (and recommended to producers) throughout the grazing season in 
suppressive anthelmintic programs that kept egg production and pasture contamination at low 
levels (Kaplan 2004). For most producers, parasite control continues to include treatments with 
anthelmintic drugs, but any veterinarian working with small ruminant producers must stress the 
importance of alternative methods of parasite control that can be used in combination with 
anthelmintics (Zajac, 2006).  
Due to growing levels of resistance in these gastrointestinal nematodes to current drugs 
and the lack of interest in developing new drugs by companies, small ruminant producers are 
desperate for solutions (Zajac, 2002). Drug resistance by nematodes has resulted in the search for 
better treatment methods including the use of non-chemical alternatives. They include production 
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practices and the use of genetics based breeding schemes to contend with anthelmintic resistance 
of GI nematodes.  
Plant based anthelmintic have also been explored for use in the elimination of GI 
nematodes with such extracts like: Garlic (Allium sativum) (Worku et al., 2009), neem 
(Azadirachta india), wormwood (Artemisia absinthium), and tobacco (Nictiana tobacum) 
(Worku et al., 2009). Other measures which have been used include reduction of stock density 
and the maximization of pasture to reduce parasite numbers as alternative management practices. 
Placing animals on a high nutritional plan was described by Zajac (2002), to aid in the 
development of an immune response allowing goats to develop some natural immunity against 
the parasites before using anthelmintics as a best management practice. Finally, substances able 
to modulate immune functions are also being incorporated in animal feed to stimulate host 
defense (Gallois et al., 2008, Hoste et al., 2008). Improvement in animal nutrition can also 
impact the immune response including gene response, protein synthesis, modification and 
degradation, metabolism, signal transduction and cellular proliferation (Afacan et al., 2012).  
The understanding of protective mechanisms regarding the initial steps of the host’s 
response to pest or parasite derived molecules that can correlate with resistance or susceptibility 
to pathogens needs to be explored for economically important pests of ruminants. This 
understanding will aid the design of immune-modulatory strategies to induce a change in the 
magnitude of immune or non-immune responses. 
2.5 Mushroom  
The term mushroom can be defined as ‘a macro fungus with a distinctive fruiting body, 
large enough to be seen with the naked eye and to be picked by hand’(Chang, 1999). The number 
of species mushrooms on earth is estimated at 140,000, yet maybe only 10% (approximately 
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14,000 named species) are known (Wasser 2002), of which only about 650 species are reported 
to be of medicinal value (Minato, 2010). Mushrooms have been appreciated and consumed for 
their nutritional value and medicinal properties in several countries over the years and have been 
used not only as a source of food but medicinal resource as well (Wasser, 2002). Researchers 
have considered mushrooms as healthy food because they are good sources of vitamins, 
minerals, proteins, and carbohydrates apart from the low level of lipids and low caloric content 
(Wasser, 2002 and Kalac, 2009). Mushroom extracts have been reported to exhibit antioxidant 
properties (Tsai et al., 2009), which makes them excellent sources of β-glucans and are rich in 
many bioactive metabolites of high medicinal value such as lectins, polysaccharides, phenolic 
and polyphenolics, terpenoids and volatile organic compounds (Kalac. 2013). The low total fat 
content and high proportion of polyunsaturated fatty acids relative to the total fatty acids of 
mushrooms are considered significant contributors to the health value of mushrooms (Sanodiya 
et al., 2009). Mushroom extracts have been shown to exhibit immumomodulator, 
antitumor/anticancer, antibacterial and antiviral, antioxidant, and antihypoglycemic activities. 
Therefore, there has been an urge to use mushrooms as an alternative method to promote animal 
health.  
2.5.1 Coriolus versicolor. Coriolus versicolor (CV) formerly known as Trametes 
versicolor is pore-bearing basidiomycetes. Its fan-shaped fruiting bodies grow in overlapping 
clusters on dead logs (Fig. 2). The top of it is zoned, usually in shades of brown, white, gray, and 
blue bands while the underside is white and bears minute pores (Hobbs, 2004). This edible 
mushroom is widely distributed all over the world in temperate zones of Asia, Europe and North 
America and may be the most common shelf fungus in the Northern Hemisphere (Cui et al., 
2003).  
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Figure 2. C. versicolor mushroom (fruiting body) growing on tree trunk (Courtesy of Frank L. 
Hoffman). 
2.5.2 Morphology. The morphological characteristics of CV fruiting body have been 
described (Cui et al., 2003) as follows: 3–5 cm across brackets that are semicircular, flattened, 
thin, and tough. Young brackets are flexible and usually occur in tiers and spread along branches. 
The upper surface is velvety and attractively marked with concentric zones of varying colors: 
brown, yellow, gray, greenish, or black. The margin is usually wavy. The mushroom has white 
spores that are oblong and cylindrical. In agitated submerged culture, the fruiting body and 
spores do not form, and the fungus grows as dispersed or pelleted mycelium. More than 120 
strains of CV have been recorded. 
The therapeutic potential of CV is gaining acceptance among patients worldwide (Lau et 
al., 2004). The active ingredients in CV are polysaccharides, in particular polysaccharide krestin 
(PSK, a protein-bound polysaccharide) and polysaccharide-peptide (PSP) (Chan and Yeung, 
2006). They exert their therapeutic effects by modulating the host’s immune response. Both 
preclinical and clinical evidences have demonstrated that extracts from CV display a wide array 
of biological activities, including stimulatory effects on the immune system and inhibition of 
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cancer growth (Zhou et al., 2007).  The aqueous extract of CV was found to be effective in 
activating T lymphocytes, B lymphocytes, macrophages, natural killer (NK) cells, and 
lymphocyte-activated killer cells (Ng, 1998), as well as promoting the production of antibodies 
and various cytokines, such as IL-2 and IL-6, and tumor necrotic factor (TNF) in vivo (Yang et 
al., 1999). Oral administration of PSP to normal mice resulted in an elevated production of 
cytokines that can stimulate the proliferation of T cells and activation to cytotoxic T cells 
(Rowan et al., 2003). CV polysaccharopeptides can remedy intestinal disorders and are beneficial 
in the therapy of opportunistic microbial infections that suppress the immune response (Cui et 
al., 2003). 
Studies have demonstrated that dietary immunomodulators such as β-glucan show 
beneficial results in a wide variety of animal species (Hahn et al., 2006). The immunostimulant 
and immunomodulatory effects of β-glucan polysaccharides result in the regeneration of the 
host’s ability to fight infections (Rieder et al., 2013). The immunomodulatory process initiates 
when the β-glucan binds to cell surface receptors of macrophages, lymphocytes and neutrophils 
(Chen et al., 2007). β-glucan activates B-lymphocytes and macrophages through toll-like 
receptors, modulating the immune system and inducing the production of cytokines (Liao et al., 
2004). These cytokines in turn activate adaptive immunity through the production of B cells for 
antibody production and stimulation of T cell differentiation to T helper (Th) 1 and Th2 cells, 
which mediate cell and humoral immunities, respectively (Bochers et al., 2008). It was also 
demonstrated that β-glucan may enhance the innate immune responses, including lymphocytes 
proliferation and antibody production (Gopalalakannan et al., 2010). An opportunity exist to 
understand the harness therapeutic potential of the use of mushroom extracts in animal health 
and production to ensure food security and meet the protein needs of the expanding world 
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population. Mushrooms seem to be a potential candidate for prebiotics as it contains 
carbohydrates like chitin, hemicellulose, β- and α-glucans, mannans, xylans and galactans. 
Prebiotics can be defined as selectively fermented ingredients that allow specific changes, both 
in the composition and/or activity in the gastrointestinal microbiota that confers benefits upon 
host well-being and health (Gibson et al., 2004). 
2.5.3 Mushrooms in Animal Health. The health benefits using mushrooms or their 
extracts in animals have been extensively reported. CV is considered as a strong potential 
candidate for drug development in treatment and suppression of DNA and RNA synthesis and 
enhances immune functions (Hsiehet al., 2002). Mushrooms and mushroom components have 
been reported to have a myriad of positive health benefits, mainly on the basis of in vitro and in 
vivo animal trials (Roupas et al., 2012). Mushrooms and mushroom components exert many of 
their positive effects on health via a balance of T helper cells, the induction of interferon-gamma 
and certain interleukins or NO-mediated mechanisms. Many of these immunomodulating effects 
are due to the polysaccharide content of mushrooms, either from β-glucan or from 
polysaccharide–protein complexes (Roupas et al., 2012). 
2.5.4 Mechanism of Action. The best-known effect of β-glucan consists of the 
augmentation of phagocytosis of granulocytes, monocytes, macrophages and dendritic cells. In 
this regard, macrophages considered being the basic effector cells in host defense against 
bacteria, viruses, parasites and tumor cells, play the most important role (Vetvicka et al., 1996). 
This innate immunity is based on non-clonal receptors (pattern recognition receptors, PRRs), 
which recognize certain molecules on the surface of invading microorganisms and are 
collectively termed as pathogen-associated molecular patterns (PAMPs). The first step of β-
glucan -macrophage interaction is binding to specific receptors (PRRs) present on a surface of 
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the macrophage cell. For β-glucan recognition, the macrophages keep several receptors at their 
disposal: TLR-2 (Toll-like receptor 2), dectin-1, CR3 (complement receptor 3), lactosylceramide 
and probably others. However, the interaction between β-glucan and CR3 receptor is established 
more effectively than at the other receptors. Binding to PRRs, such as toll-like receptor-4 
(TLR4), dectin-1 and complement receptor 3 (CR3) by polysaccharides can activate immune 
responses by enhancing the secretion of TNF-alpha, IL-6 and other inflammatory cytokines. 
Pathogen recognition receptors also serve to bind ligands that prime immune responses (Ofodile, 
2007). While there has been considerable research on how isolated β-glucan activates cytokine 
production through dectin-1 and CR3, there are few reports on the mechanisms of how 
traditionally used medicinal mushroom preparations that contain polysaccharides, interact with 
PRR (Price et al., 2010). However, there are no published reports on the effects of Coriolus 
versicolor mushroom extracts on PRR pathways. No work has been done on goats. 
2.6 Toll-like Receptors 
 Animals live in a wide variety of microbe-rich environments and hence it is crucial to 
have a sensitive innate defense mechanism which relies in part by recognizing conserved 
molecules that are unique to some classes of potential pathogens (Tirumurugaan et al., 2010). It 
is very important to understand the innate immunity against microbial components and its critical 
role in host defense against infection. Toll-like receptors (TLRs) are a highly conserved group of 
proteins that have been identified in mammals (Medzhitov et al., 1997). Following the discovery 
of Toll-like receptors (TLRs) in the mid-1990s it has been clearly shown that pathogen 
recognition by the innate immune system is broadly specific, relying on germline-encoded 
pattern-recognition receptors (PRRs) that have evolved to detect relatively conserved 
components of pathogens referred to as pathogen associated molecular patterns (PAMPs) 
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(Janeway et al., 2002). The PAMPs recognized by TLRs include lipids, lipoproteins, proteins and 
nucleic acids derived from a wide range of microbes such as bacteria, viruses, parasites and fungi 
(Akira et al., 2006) which initiates a complex signaling cascade to activate a wide variety of 
transcription factors and inflammatory cytokines (Takeda et al., 2005).  
The TLR family consists of ten receptors: TLR-1 through TLR-10, which are very 
important in the identification of microbes (Takeda et al., 2005). The coding regions within the 
sheep and goats TLR 1-10 genes have been sequenced and found to be conserved and highly 
similar in nucleotide composition (Raja et al., 2011). Tirumurugaan et al. (2010), used bovine 
specific primers to amplify goat TLR mRNA. Toll-like receptor 4 (TLR-4) recognizes 
lipopolysaccharide, which is associated with the protein in gram-positive bacteria membranes 
and is bound; pathogen recognition activates the innate immune response (Akira et al., 2004). 
Effect of toll-like receptors has not been studied. 
2.7 Cytokines  
The nature of an immune response is greatly influenced by the pattern of cytokines 
secreted during that response. Cytokines are small proteins that transmit information from one 
cell to another. The analysis of cytokines secreted by immune cells in response to infectious 
agents is crucial to understand pathogenesis and immunity. Most cells in the body produce 
cytokines during inflammatory processes which represent a large series of regulatory proteins of 
the immunologic system. Many cytokines are referred to as interleukins, a name indicating that 
they are secreted by some leukocytes and act upon other leukocytes. Two general patterns of 
cytokine secretion by such cells have been described: In the Th1 response cytokines initiate cell 
mediated reactions defined as the activation of macrophages to combat infectious pathogens by 
releasing IL-1, IL-2, IL-8, and IL-12 to activate inflammation (Raghupathy, 2001). In the Th2 
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response, T-helper cells activate B-cells; interleukins IL-4, IL-5, IL-6, IL-10 and IL-13 are 
released to counter infectious agents caused by extracellular organisms (Raghupathy, 2001).  
5  
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6 CHAPTER 3 
7 Materials and Methods  
3.1 Animals 
 Fifteen female SpanishXBoer goats were selected from the herd at North Carolina 
Agricultural and Technical University (NCA&TSU) Small Ruminant Research Unit. All animals 
were ear tagged prior to the study. Animals were clinically healthy and not under any treatment 
prior to the study. It was approved by Institutional Animal Care and Use Committee (IACUC). 
Initial screening was carried out to determine body weight, body condition, packed cell volume 
and the level of coccidian oocyst and H. Conturtus egg in fecal sample. 
3.2 Experimental Design  
A complete randomized design was used in assigning treatment to each before screening. 
A two period crossover design was conducted (Park et al., 2010) to analyze all variables.  
3.3 Housing  
During the experiment the goats were housed in a barn with wood shavings at night and 
pasture during the day. Water and feed supply were provided ad libitum. The barn had good 
sanitation and good management. 
3.4 Feeding 
The animals were supplemented under balanced diet feed (Southern States Quality kid 
and Goat Feed) which contained a high-protein, high-energy mixture fortified with vitamins and 
minerals such as ammonium chloride, copper and zinc. The goats were fed two pounds of feed 
per animal once a day. Also the animals were fed with hay ad libitum. 
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3.5 Preparation of Mushroom Extracts  
CorPet powder (Coriolus versicolor) was purchased from Mycology Research Labs Ltd 
(United Kingdom). Twenty-five (25) grams of CorPet was weighed out and stirred in 250 ml of 
sterile endotoxin free distilled water. Protein content for the mushroom extract was determined 
using the PierceTM Bicinchoninic Acid (BCA) Assay kit (Rockford, IL) to determine the level of 
protein to be administered to the animals. 
3.5.1 Extract Preparation. Heated extracts was prepared by first weighing 25 g of 
CorPet powder in 250 ml of distilled water and heated with stirring for 20 minutes. The extracts 
were left to cool and then stored at 40C. Cold extracts were prepared by weighing 25 g of CorPet 
powder in 250 ml of distilled water and stirred for 20 minutes and stored in 40C.  
3.5.2 Drench Administration. Ten (10) ml of the extract was given to each goat on daily 
basis for 60 days. Ten (10) ml of distilled water was also given to the control group daily for 60 
days. Treatments were reversed after the first 30 days in a crossover design.  
3.6 Sample Collection  
 All samples were collected and evaluated once a week throughout the experiment. 
3.6.1 Body weight. Goats were weighed on a portable scale in Kg before they were fed in 
the morning.  
3.6.2 Body condition Scores. Body condition was determined by physically assessing 
the rib areas using firm pressure with the fingers and running fingers down the goat’s spine from 
the shoulders to the tail head, and degree of fat cushion over these bones determines the score. 
Body condition refers to the fleshiness of the goat which is scored from 1 to 5, where 1 is very 
lean, 2 is lean, 3 is moderately good condition, 4 is fat, and 5 is obese (Mendizabel et al., 2010).  
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3.6.3 FAMACHA Eye Color Score. The FAMACHA chart is a parasite monitoring 
system used to correlate fecal egg count (parasitic load) with color of the ocular conjunctiva 
(Kaplan et al., 2004). Using this method, animals were classified into 5 categories according to 
eye mucus color; category number 1 = red, non-anemic; 2= red-pink, non-anemic; 3 = pink, 
mildly anemic; 4 =pink-white, anemic; 5 = white, severely anemic.  
3.6.4 Collection of Fecal Samples. Fecal samples were collected by applying lubricant 
and inserting the index middle finger directly into the rectum wearing sterile gloves for each 
animal. Collected samples were placed in labeled clean zip-lock plastic bags to determine fecal 
egg count.  
3.7 Fecal Egg Count 
 A modified McMaster technique was used for fecal egg count as described by Whitlock 
(Kaplan et al., 2004). Two (2) grams of feces were weighed and dissolved in 28 ml of saturated 
sodium chloride to cause parasites eggs to float to the top of the liquid. Pellets were broken down 
using a spatula. Ten (10) ml syringe was used to transfer aliquots of the solution into both 
McMaster slide chambers and examined under an Olympus B X40 microscope using 10X 
magnification according to the Paracount-EPGTM Fecal Analysis Kit (Chalex Corporation, 
Wallowa, OR). The number of coccidia oocyst and H. Conturtus egg were counted in duplicate, 
the average was calculated, and then multiplied by 50 to get the eggs per gram (epg) of feces for 
each animal (Kaplan et al., 2004). 
3.8 Isolation of Microbial DNA from Fecal Samples  
The QIAamp (R) DNA isolation stool mini kit (50) (QIAGEN Sciences, Maryland) was 
used to isolate DNA from fecal samples as recommended by the manufacturer. Briefly 200 mg of 
fecal samples from each goat was weighed and transferred into a clean tube and placed on ice. 
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Two (2) ml of lysis buffer (ASL) buffer was then added to each tube. Tubes were vortexed 
continuously for I minute until the stool sample was thoroughly homogenized. The stool lysate 
of 1.6 ml was pipette into a labeled 2ml micro centrifuge tube. The suspension was heated for 5 
minutes at 700C. The tubes were vortexed for 15 seconds and centrifuged at full speed for 1 
minute to pellet stool particles. The supernantant (1.2ml) was pipetted into a new 2 ml micro 
centrifuge tube. One inhibitEX tablet was added to each sample and vortexed immediately and 
continuously for 1 minute at room temperature to allow inhibitors to adsorb to the inhibitEX 
matrix. Samples were then centrifuged at full speed for 3 minutes to pellet stool particles and 
inhibitors bound to inhibitEX matrix. The supernatant was pipetted into a new 1.5 ml micro 
centrifuge tube and the pellet was discarded.  
The sample was centrifuged at full speed for 3 minutes. The supernatant (200 µl) was 
transferred into a 1.5 ml micro centrifuge tube containing 15 µl of proteinase K. AL buffer (200 
µl ) was added to each tube and vortexed for 15 seconds. Tubes were then incubated for 10 
minutes at 700C. Ethanol (200 µl) (96%) was added to the lysate and mixed by vortexing. The lid 
of a new QIAamp spin column was labeled and placed in a 2 ml collection tube. The complete 
lysate was carefully transferred to the QIAamp spin column without moistening the rim. The cap 
was properly closed and centrifuged at full speed for 1 minute. The QIAamp spin column was 
placed in a new 2 ml collection tube, and the tube containing the filtrate was discarded. The 
QIAamp spin column was carefully opened and 500 µl of buffer AW1 was added. The cap was 
closed and centrifuged at full speed for 1 minute. The QIAamp spin column was placed in a new 
2 ml collection tube and the collection tube containing the filtrate was discarded. Wash buffer 
AW2 (500 µl) was added and centrifuged at full speed for 3 minutes. The collection tube 
containing the filtrate was discarded. The QIAamp spin column was transferred to a new 2 ml 
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collection tube and centrifuged at full speed for 1 minute. The old collection tube with the filtrate 
was discarded. The QIAamp spin column was transferred into a new-labeled 1.5 ml 
microcentrifuge tube and then 200 µl of buffer AE was then pipetted directly onto the QIAamp 
membrane. The cap was closed and incubated at RT for 1 minute, and then centrifuged at full 
speed for 1 minute to elute DNA. The concentration (260 nm) and quality or purity (260/280 nm) 
of the isolated DNA samples were determined using the Nanodrop Spectrophotometer 1000 3.7.1 
(Thermo Scientific Inc., MA). 
3.9 Blood collection 
Blood samples (15 ml) were collected from the junglar vein into 2.5 ml PAXgene blood 
RNA tubes (QIAGEN Inc, Valencia,CA) for extraction of RNA. The PAXgene tube contains a 
reagent that immediately stabilizes intracellular RNA for 3 days at room temperature (18-250C) 
and 5 days at 2-80C. Blood ten (10) ml was also collected into vacutainer tubes containing 0.9ml 
of Acid Citrate Dextrose for isolation of neutrophils. Blood was also used to determine packed 
cell volume and blood smears were prepared for total white blood cell differential counts. 
3.10 Laboratory Analysis 
3.10.1 Packed Cell Volume. Heaprinzed hematocrit micro-Capillary tubes (Drummond 
cat # 1-000-7500-HC/5) were used to collect blood in duplicate from tubes containing 
Ethylenediaminetetraacetic (BD, Franklin Lakes, NJ). Mico-capillary tubes were sealed with 
clay sealant (Fisher Scientific Inc. Pittsburg, PA) and placed in numbered duplicate sample slots 
and then centrifuged for 5 minutes at 14,000 rpm in an IEC MB Micro Hematocrit centrifuge 
(Damon/IEC Division, Needham, MA). The capillary tubes were then placed in micro capillary 
reader (BD, Franklin Lakes, NJ) to determine the PCV. 
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3.10.2 Differential White Blood Cell Count. A thin blood smear was prepared in 
duplicate by placing a drop of blood (approximately 4 mm in diameter) on one end of a micro 
slide. A spreader slide was used at 450 angle to disperse the blood over the slides length in order 
to space out cells far enough to be counted and differentiated. The slide was left to air dry at 
room temperature then stained with Sure Stain Wright CS-432 solution according to the 
manufacturer’s instructions (Fisher Scientific Inc. Pittsburgh, PA). The slides were dipped in 
Wright stain for 10 seconds then in deionized water for 15 seconds, and finally rinsed by dipping 
in fresh deionized water for 10 seconds. The slides were left to dry at room temperature. White 
blood cell differential counts were carried out by placing slides under 100X magnification of 
Olympus B X40 microscope using mineral oil (Sigma-Aldrich St Louis, MO). Counting was 
performed using Fisher Five Button Lab Counter (Fisher Scientific Inc. Pittsburgh, PA). Slides 
were counted in duplicate to identify the percentage of lymphocytes, neutrophils, monocytes, 
eosinophils, and basophils. 
3.11 Plasma Preparation 
 Whole blood in a 15 ml tube containing anticoagulant citrate dextrose (ACD) was 
centrifuged at 3600 rpm for 20 minutes to separate plasma from blood cells. Plasma, which was 
at the top surface, was collected using a pipette into a 10 ml tube and stored at -700C.  
3.11.1 Bicinchoninic Acid Assay (BCA). PierceTM  BCA Assay kit (Rockford, IL) was 
used to determine the total protein concentration content from plasma isolated from whole blood. 
Protein standards were prepared (Appendix A). 
Briefly 25 µl of each standard and unknown sample was pipetted into a 96-microplate 
well (Thermo ScientificTM PierceTM, Rockford, IL). Working reagent (WR) was prepared by 
mixing 50 parts of BCA reagent A with 1 part of BCA reagent B. Two hundred (200) µl of the 
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WR was added to each well and mixed thoroughly on a plate shaker for 30 seconds. The plate 
was then covered and incubated at 370C for 30 minutes. Plates were cooled to room temperature 
(RT). A standard curve was created using the protein standard samples at 0µm/ml, 25µm/ml, 
125µm/ml, 250µm/ml, 500µm/ml, 750µm/ml, 1000µm/ml, 1500µm/ml and 2000µm/ml and the 
absorbance was measured at 562nm on a plate reader (BioTek Instruments Inc, Winooski VT). 
Unknown sample concentrations were quantified by interpolating the optical density from the 
standard curve and also the line of best fit. 
3.11.2 Evaluation of the Secretion of Cytokines 
3.11.2.1 Preparation of Protein standards. The human inflammation ELISA strip protein 
standards (Signosis Inc, Santa Clara, CA) was used to profile selected cytokines. Two hundred 
(200) µl of the diluent buffer was added to the well of the first strip of a 96 well plate, and then 
100 µl of diluent buffer was added to the remaining wells of the strips according (See Appendix 
C). Protein standards were added to the first strip. A multi-channel pipette was used to mix the 
dilutions and transfer 100 µl to the next dilution wells. This transfer was done until the 5th strip. 
No transfer was done to the 6th strip. 
3.11.2.2 Cytokines. The Human Inflammation ELISA kit (Signosis Inc, Santa Clara, CA) 
was used to determine pro-inflammatory cytokine amounts of eight cytokines: Tumor necrosis 
factor-alpha (TNF-α), interferon regulator (IFNr), granulocyte-colony stimulating factor (G-
CSF), granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-1a (IL-1a), 
interleukin-8 (IL-8), interferon inducible protein 10 (IP-10), and regulated on activation, normal 
T expressed and secreted (RANTES) in pooled blood plasma. The assay was done in triplicate 
according to the given protocol. 
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 Briefly according to the manufacturer, seals of the 96 well plates were properly removed 
and then 100 µl of standard, control and treatment plasma samples were added into each well in 
triplicate and incubated for 1 hour at room temperature with gentle shaking.  Following 
incubation each well was aspirated and washed by adding 200 µl of 1X wash buffer. This 
process was repeated three times for a total of three washes. The plate was inverted onto a towel 
after the final wash to ensure the removal of excess liquid. One hundred (100) µl of diluted 
biotin-labeled antibody mixture was added to each well and incubated for 1 hour with gentle 
shaking. Each well was aspirated and washed by adding 200 µl of 1X wash buffer. This process 
is repeated three times for a total of three washes. The plate was inverted onto a towel after the 
final wash to ensure the removal of excess liquid. Afterwards, 100 µl of diluted streptavidin-
HRP conjugate was added to each well and incubated for 45 minutes at room temperature with 
gentle shaking. Each well was aspirated as before and washed by adding 200 µl of 1X wash 
buffer. This process was repeated three times for a total of three washes. The plate was inverted 
onto a towel after the final wash to ensure the removal of excess liquid. A 100 µl of substrate 
solution was added to each well and incubated for 25 minutes at room temperature, followed by 
the addition of 50 µl of stop solution into each well. There was a color change from blue to 
yellow. The optical density was read at an absorbance of 450 nm using a micro plate reader 
(BioTek Instruments Inc, Winooski VT). A standard curve was generated to identify optical 
density of unknown samples. Unknown sample concentrations were quantified by interpolating 
the optical density from the standard curve and also the line of best fit. 
3.12 Sample Preparation  
The plasma protein sample was mixed with an equal volume of 2X treatment buffer 
(Laemmli, 1970) and boiled for 2 minutes to denature the proteins.  
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3.12.1 Sodium Dodecyl Sulphate Poly Acrylamide Gel Electrophoresis (SDS-PAGE). 
A discontinuous SDS-PAGE was done using 0.75-mm thick slab gels with a 4.5% stacking gel 
and 12 % separating gel. Monomer gel solution was poured into glass gel cassettes. Deionized 
water was added slowly over the monomer solution to ensure that the top of the gel was even. 
After 30 minutes, the water was discarded and running gel overlay was added on the gel. The 
gels polymerized overnight at room temperature. The gel overlay was then decanted. A 4.5% 
stacking gel solution was prepared and pipetted onto the 12 % separating gel and a comb was 
inserted into the stacking gel. The stacking gel was allowed to polymerize for 30 minutes. The 
comb was removed after polymerization was complete. The samples were carefully loaded in the 
appropriate wells. Electrophoresis was carried out with a current of 100 watts for approximately 
1 to 2 hours using the LKB Slab Gel System and the Ephortec® 1000 volt power supply unit. 
The gels were silver stained by the method of Tsai and Frasch (1982).  
3.12.2 Silver Staining. Slab gels were stained using the method of Tsai and Frasch 
(1982). Powder-free gloves were used throughout the silver staining procedure. All steps were 
performed at room temperature. Gels were transferred from gel cassettes into staining trays filled 
with fixative (40% ethanol (ETOH), 5% acetic acid, and 55% deionized water) and placed on a 
shaker overnight. After the overnight fixing step, the fixative was discarded and a freshly 
prepared oxidizer solution (0.7g oxidizer, 100ml of fixative) was added. The gels were placed on 
the shaker for 5 minutes. The gels were washed in deionized water for 15 minutes. This step was 
repeated twice. The gels were incubated for 30 minutes in a silver stain (Appendix F) prepared 
fresh and followed by three 10 minute washes and developed in a solution containing citric acid 
(50mg), 37% formaldehyde (0.5ml) and 1 liter DH2O, and stored in 5% acetic acid. 
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3.13 Detection of Prostaglandin E2α 
Prostaglandin supernatant of control (PBS) and treated whole blood was evaluated using 
commercial Enzyme-linked immunosorbent assay (Cayman) following manufacturer’s 
instructions. (See appendix for standard and buffer preparations). 
One Hundred (100) μl of EIA Buffer was added to NSB wells, fifty (50) μl of EIA Buffer 
was also added to the B0 wells. This was followed by the addition of Prostaglandin E2 EIA 
Standards to wells. Fifty (50) μl from tube #8 was added to both of the lowest standard wells 
(S8). Fifty (50) μl from tube #7 was also added to each of the next two standard wells (S7). The 
procedure was continued until all the standards were aliquoted. The same pipette tip was used to 
aliquot all the standards. This was followed by adding fifty (50) μl of plasma sample for each 
treatment into each well in triplicates. Fifty (50) μl of AChE Tracer was added to each well 
except the TA and the Blk wells. Fifty (50) μl Prostaglandin E2α Monoclonal Antibody was 
added to each well except the TA, the NSB, and the Blk wells. The plate was covered with a 
plastic film and incubated over night at 4°C. The plate was developed by empting and rinsing 
five times with Wash Buffer. Two hundred (200) μl of Ellman’s Reagent was added to each well. 
Five (5) μl of tracer was added to the TA well. The plate was covered with plastic film and 
placed on an orbital shaker equipped with a large, flat cover for 90 minutes to develop in the 
dark. The plate was read by wiping with a clean tissue to remove fingerprints, dirt, etc. The plate 
cover was removed and inserted into a micro plate reader (BioTek) and read at wavelengths 405, 
410, 415, 417 and 420 nm. SAS was used to plot %B/B0 for standards S1-S8 versus PGE2α 
concentration using a logit transformation.  
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3.14 Isolation of RNA from Goat peripheral Blood 
 Total RNA was extracted from blood collected in PaxGene RNA collection tubes 
(QIAGEN Inc, Valencia, CA) using the ZR whole-blood Total RNA kit (Zymo Research, 
Orange, CA), as recommended by the manufacturer. Briefly, tubes were centrifuged at 3600 rpm 
for 15 minutes at 40C. The supernatant was removed and 5 ml of dietylpyrocarbonate (DEPC) 
treated water was added, vortexed and centrifuged for 10 minutes. The supernatant was removed 
and 3 ml of blood RNA buffer was added and incubated for 10 minutes on ice. Six hundred (600) 
µl of the mixture was transferred into a column with a collection tube and centrifuged at 14,000 
rpm for 2 minutes. The supernatant was transferred to a fresh column and 400 µl of RNA was 
buffer was added to the column and centrifuged at 12,000 rpm for 30 seconds, then transferred 
into an RNAase free tube. One hundred (100) µl of RNA recovery buffer was then added to the 
column and centrifuged at 12,000 rpm for 30 seconds. One hundred (100) µl of ethanol was then 
added to the column with a collection tube and centrifuged at 12,000 rpm for 30 seconds. Four 
hundred (400) µl of RNA prep buffer was then added to the column and centrifuged at 12,000 
rpm for 1 minute. The flow through was discarded. Eight hundred (800) µl of RNA wash buffer 
was then added to the column and centrifuged at 13,000 rpm for 30 seconds. The flow through 
was discarded. This step was repeated twice.  The column was then transferred into an RNase 
free tube. 10 µl of DNase free water was then added to the column and centrifuged at 10,000 rpm 
for 30 seconds. This step was repeated again and elute was incubated at 650C for 5 minutes 
which was now stored at 200C. 
3.15 Neutrophil Isolation 
 Neutrophil were isolated from whole blood using the modified Carlson and Kaneko 
method (Carlson and Kineko, 1973). Briefly, whole Blood from each goat was placed into a 50 
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ml polypropylene conical tube, mixed, balanced and placed on ice. The blood was centrifuged on 
a swinging bucket rotor (Eppendorf Centrifuge 5810 R) at 3500 rpm (1800 g) at 40C for 20 
minutes. Centrifugation leads to the separation of blood components into plasma, buffy coat and 
red blood cell (RBC) layer. Using a vacuum, plasma, buffy coat and 1/3 of the RBC layer of 
each tube was carefully aspirated. The caps were replaced and gently inverted to re-suspend 
neutrophil/red cell layer and immediately 20 ml of ice cold DEPC treated distilled water was 
added. Red blood cells were lysed by inverting and rotating the tube for 45 seconds. Ten (10) ml 
of 2.7% saline was added to restore isotonicity and the contents were mixed by rotating and 
inverting the tube. Cells were kept cold by returning to ice periodically followed by centrifuging 
at 2000 RPM (700 g) at 40C for 2 minutes and discarding the supernatant. The cells were 
resuspended in 10 ml of ice cold PBS (pH 7.4) to the pellet and then it was gently inverted and 
rotated manually. The whole procedure was repeated in other to obtain a clear white pellet. After 
the last addition of cold PBS, cells were placed on ice. 
3.15.1 Determination of Total Cell Count and Viability of Neutrophils. Viability and 
total cell count of isolated neutrophils was determined by using the Trypan blue dye exclusion 
method. Isolated neutrophil were mixed with Trypan blue (Sigma-Aldrich cat #T8154) in a ratio 
of 1:1. 10 µl of the mixture was then mixed properly and placed on a TC10 TM system counting 
slide. The slide was then inserted into the TC10 TM system (Biorad) to count. The number of 
cells that had not taken up the dye was counted as live cells and the results were given in % of 
live (viable) cells. Total number of cells was also obtained. 
3.16 Isolation of Total RNA from Neutrophils 
 Neutrophils were adjusted to a concentration of 1x107 cells/ml using PBS and re-
suspended in 1 ml of Tri-reagent (Molecular Research Centre, USA). The recommended protocol 
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was used. Briefly, cells were incubated at room temperature for 5 minutes. Two hundred (200) µl 
of chloroform was added to the tubes shaken manually for 15 seconds and incubated at room 
temperature for 15 minutes. This was followed by centrifugation at 1200 g (9,000 RPM in 
Eppendorf Model 5810R Centrifuge) at 40C for 15 minutes. The aqueous phase containing the 
RNA was transferred to a clean tube. To the aqueous phase, 500 µl of isopropanol was added and 
incubated at 40C for 90 minutes to precipitate RNA. Samples were then centrifuged at 12,000 g 
at 40C for 8 minutes. The supernatant was discarded. The RNA pellet was then washed with 1 ml 
of 95% ethanol. Ethanol was decanted and the pellet was allowed to dry for 15 minutes at room 
temperature. The dried RNA pellet was dissolved in 30 µl of sterile DEPC-treated water and then 
stored at -800C until further use. 
3.16.1 RNA Concentration and Purity. The ND-1000 UV/VIS nanodrop (NanoDrop 
Technologies) spectrophotometer was used to determine the concentration and purity of isolated 
RNA from PaxGene tubes and neutrophils and DNA from fecal samples. RNase free water was 
used as a blank. One (1) µl of RNA was dropped on the nanodrop and the concentration and 
purity was determined. Optical densities were read at A260/280 for nucleic acid purity. 
3.17 Preparation of cDNA from PMN RNA 
Complementary DNA (cDNA) was synthesized using a RETRO script Kit (Ambion Inc., 
Austin, TX) by taking 2 µg of total RNA from each sample and adding 2 µl of Oligo (dT) 
(Ambion Inc., Austin, TX) ). The final volume was adjusted to 12 µl by the addition of nuclease 
free water in a PCR reaction tube. The samples were vortexed, spun and placed into a 
thermocycler (MWG Biotech, Martinsried, Germany) then heated for 3 min at 85ºC, removed 
and placed on ice. Next, the remaining reverse transcription components were added to each 
sample, 2 µl 10X RT buffer, 4 µL dNTP mix, 1 µl RNase Inhibitor and 1 µl reverse transcriptase 
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(RT) (Ambion Inc., Austin, TX) totaling 20 µL in volume. The tubes were vortexed, spun down 
and placed into the thermocycler for incubation at 44ºC for 1 hr. to activate reverse transcription 
followed by incubation at 92ºC for 10 min to stop the action. Finally, the cDNA products were 
measured for purity and concentration using the Nanodrop spectrophotometer (Thermo Scientific 
Inc., Waltham, MA) as described above and stored at -20ºC. 
3.18 Real Time-PCR 
 The Qiagen Human Toll-like Receptor RT-PCR kit (Qiagen, Valencia, CA) was used to 
detect transcription. Ninety-six-well plates containing gene-specific primer sets for 84 relevant 
TLR pathway genes, 5 housekeeping genes, and 2 negative controls were used. After performing 
thermal cycling (according to the manufacturer's protocol), real-time amplification data were 
gathered by using manufacturers supplied software.  
3.19 The Livak Method  
 Gene expression was normalized to internal controls GAPDH (housekeeping genes) to 
determine the fold change in gene expression between test and control samples by using the 
2−ΔΔCt method (Livak and Schmittgen, 2001). The C(t) for each gene from the different samples 
was standardized to the sample GAPDH value [ΔC(t) = gene C(t) − GAPDH C(t)], and this value 
was then compared using the ΔΔC(t) method to determine the fold change {fold change = 
[2^(−ΔΔCT)]}. The significance value for the fold change in each gene fold change was 
calculated as the difference in gene expression between test samples (hot and cold) and control 
sample (water). A positive value indicates gene upregulation, and a negative value indicates gene 
downregulation. 
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3.20 Statistical Analysis 
 A crossover analysis, repeated measures and ANOVA was performed on all variables 
using the statistical analysis software package SAS (Cody and Smith 1997). Variables included 
FAMACHA, body weight, body condition, FEC, PCV, differential white blood cell count, DNA 
concentration, protein concentration and purity. To examine significance of the treatment 
differences, the F value was calculated by comparing the computed F value with the tabular F at 
5% level of significance or P<0.05. All treatment differences with computed F values greater 
than tabulated F values at 5% of significance were considered significant. Treatment differences 
with computed F value smaller or equal to the tabulated F value at 5% level of significance were 
considered not significant. A Pierson correlation and coefficient was used to determine 
correlation between variables. 
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8 CHAPTER 4 
9 Results and Discussion 
4.1 Body Weight 
Initial weight of goats used in this experiment had an average weight of >52 kg across all 
groups. There was no significant difference between treatments and control (p<0.1045) at the 
end of the study. During the last 4 weeks, there was a time effect (p<0.001) and also correlation 
between body weight and lymphocyte cell count (r=0.22, p<0.0028). There was no effect of 
CorPet mushroom on body weight. The average mean weight for control was 66.1 kg (Fig. 3). 
However CorPet treatment did have an effect on body weight gain, over time, it resulted in a 
mean weight of 62.7 kg in the treated animals. Results obtained were within the range of a 
normal adult female Boer goat (Coffey, 2002). Goats used in this study were 3 weeks after 
weaning and an increase in weight was expected across all treatments. Diet and feed were kept 
constant during experimental period in other to rule out any source of variation. 
Body weight is an important parameter in determining the health status of an animal over 
a certain period of time. A decline in weight can be associated with parasitic infection, high 
temperatures that stress the animal and also lack of appropriate nutrition. It is expected that 
animals keep a relatively consistent body weight during growth. Healthy normal adult female 
Boer goats have a body weight that ranges from 55 kg to 90 kg (Coffey, 2002). In general, 
animal studies have been previously reported in the literature and these showed that mushroom 
enriched diet had no effect on body weight (Handayani et al., 2012).  Also a study that was 
carried out on the effect of Pleurotus ostreatus on the effect of weight gain by Daneshamand 
(2011), showed that supplementation of mushroom or probiotic had no effect on weight gain 
during the entire experiment.  
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Figure 3. Effect of CorPet on Body Weight (p>0.05) 
4.2 Body Condition  
 CorPet mushroom probiotic had no effect on body. There was no significant difference in 
body condition between animals in the control and treatment groups (Fig. 4). The body condition 
scores were in the range of 2 to 3 indicating a healthy animal condition (Mendizabel et al., 2011). 
CorPet mushroom probiotic had no effect on body condition. Results in this study shows that 
body condition scores could be used to identify goats which are anemic. Body condition scores is 
one of the tools goat farmers can use to achieve proper management of body reserves and has 
proved to be an effective and easy to use method (Mendizabal et al., 2011). 
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Figure 4. Effect of CorPet on Body Condition Scores (p>0.05). 
4.3 FAMACHA 
 The FAMACHA scores were similar between control and treatment groups. There was 
no significant difference between treatments and control. There was no correlation between eye 
scores and PCV. The FAMACHA score results were in the range of red (FAMACHA = 1) to 
red-pink (FAMACHA = 2) indicating that anemia was generally not a major problem in the 
study population. This is an effective tool for identifying anemic goats (Kaplan et al, 2004).  
The FAMACHA© method can be used as a safe and reliable approach to reducing 
pressure in goats on the selection for anthelmintics in relation to routine non-selective treatment 
for worm control (Kaplan et al., 2004). This tool could also be used to reduce cost and delay the 
development of anthelmintic resistance. It can also be used to improve the genetic resistance of 
individual herds or flocks (Bath et al., 2001). 
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4.4 Packed Cell Volume 
 There was no significant difference between treated and control animals. Ogbe et al., 
(2009) reported that there was no effect of aqueous mushroom extract of Ganoderma lucidum on 
PCV which correlates with the result obtained in this study. However was a time effect for the 
first four weeks (p<0.05) and the last four weeks (p<0.002) which may be associated with 
infection as the animals were on pasture. On a weekly base the treatment group had a lower PCV 
compared to control. The control group had an average PCV of 26% (Fig. %). A normal PCV for 
an adult goat ranges from 24 to 48% (Karki, 2008). PCV is an important tool in the diagnosis of 
parasitic infection (Vatta et al., 2002).  Kaplan et al., (2004) reported a correlation between PCV 
and FEC but there was no correlation between FEC and PCV in this study. The level of infection 
may have been low and not caused anemic conditions. 
The PCV obtained in this study was within the range of a healthy goat. Low PCV may be 
indicative of anemia, which is an undesirable condition that points to a compromised health 
status of the animal. It is also an 
  
Figure 5. Effect of CorPet on PCV in Percentage. 
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4.5 Fecal Egg Count 
4.5.1 Haemochus. Haemonchus contortus eggs and coccida oocytes were found in fecal 
samples. There was no significant difference between control and treatments. An average mean 
of 350 epg was obtained across treatments. However there was an observed trend of increase in 
H. Contortus egg count in the first 3 weeks compared to a decrease in the last 5 weeks with 
CorPet treatment (Fig. 6).   
 
Figure 6. The Effect of CorPet Extracts on Haemochus Eggs Per Gram Feces. 
4.5.2 Coccidia. There was no significant difference between treatments and control. 
There was an observable trend in the results obtained. At the beginning of the experiment there 
was a high oocyst count (Fig. 7). During the switch there was a decrease in oocyst count. There 
was no effect of CorPet extracts on coccidian oocyst count. Haemochus egg count and Coccidia 
oocyst count started off at a high rate but reduced after the first 4 weeks in treated and control 
animals. Cold extract treatment had fewer oocysts than the control in week 2, 3, 4, 5 and 7. Hot 
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extract treatment tended to increase; maybe extraction method had an effect. 
 
Figure 7. The Effect of CorPet mushroom Extracts on Coccidia Oocyst per Gram Feces. 
Fecal egg count is a parameter widely used to determine parasitic infection in animals 
(Kaplan et al., 2004). Basically a high FEC is associated with an elevated presence of adult 
parasites in their productive stage in the hosts’ digestive system (Kaplan et al., 2004). It is a tool 
to help a scientist to determine the presence of gastrointestinal nematode parasites and severity of 
it. Coccidiosis is one of the most important diseases of goats in the United States because of its 
effect on productivity, especially growing kids (Levine, 1985). Prevalence of Eimeria infection 
is common and contributes to production losses (Valentine et al., 2007). There are some reports 
demonstrating positive effects from feeding fungal myceliated grain to chickens (Willis et al., 
2009) and these researchers have observed its potential to control coccidiosis. In another study, 
Ogbe et al. (2009) reported that the wild mushroom (Ganoderma lucidum) used to treat E. tenella 
infected broilers resulted in a reduction in the number of E. tenella oocysts shed in the faeces and 
led to improved weight gain. 
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Mushroom extracts can impact gastrointestinal nematode infections under certain 
conditions and therefore may eventually play a significant role in an integrated GIN management 
protocol for small ruminants. Bioactive compounds or polysaccharides are known to play vital 
roles in enhancing health; they block colonization of the intestine by pathogens, thereby 
improving their elimination from the body (Elmusharaf et al., 2006). 
4.6 Microbial DNA in Fecal samples 
The concentration and purity of the microbial DNA isolated from fecal samples is an 
indicator of the impact of diet on the microbial population in the rumen and impacts goat 
production and health. Samples from treatment and control groups were analyzed for week 0, 4 
and 8. During the first week DNA concentration ranged from 14 to 19 ng/µl compared to the 8th 
week, which ranged from 5 to 16 ng/µl (Fig. 8). CorPet treatment reduced fecal DNA 
concentration from the observable trend.  
 
Figure 8. Concentration of Microbial DNA in fecal samples ng/µl for week 0(1), week 4(2) and 
week 8(3). 
There are other results indicating the effect of mushroom on the microbial flora. 
Varshney et al., (2013) reported that when white button mushroom was added to the diet of mice, 
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it changed the composition of the normal flora which resulted in better control of inflammation 
and resolution of infection. This may also correlate to the result obtained in this study. Hot 
extract treatment tends to decrease microbial shedding. 
4.7 White Blood Cell Differential Count 
 There was no significant difference in the percentages of neutrophils, lymphocytes, 
monocytes, basophils and eosinophils (p<0.5222) between treatments and control groups. There 
was a strong negative correlation between neutrophils and lymphocytes (r=-0.94, p<0.0001) as 
well as neutrophils and monocytes (r=-0.19, p<0.0470). Over time there was a significant 
increase in the last four weeks in the eosinophil count (p<0.0001). The higher production of 
eosinophils observed suggests a potential role in combating GI nematode infections (Balic et al., 
2006). Over time there was a significant increase of lymphocyte count (p<0.007) and a decrease 
in neutrophil count (p<0.001) during the last four weeks (Fig. 9 & 10). 
 
Figure 9. Effect of CorPet on Lympocyte Cell Count in Percentage. 
The high lymphocyte counts in animals in this study might be attributed to stress and 
immune response to the environment which harbors various detectable and undetectable parasitic 
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organisms. The normal value for white blood cell differential count in goats are 30-48% 
neutrophils, 50-70% lymphocytes, 0-1% basophils, 0-8% monocytes and 1-8% eosinophils 
(Khan et al., 2010). 
There was no effect of CorPet on differential white blood cell count. Stimulation of 
production of White blood cells (WBC) in an immunosuppressed animal model has been 
classified as an immunomodulatory effect (Kyakulaga et al., 2013). Some other reports have 
shown the positive effects of mushroom extracts on differential white blood cell count. 
Kyakulaga et al., (2013), reported that aqueous extracts of Auricularia sp and Pleurotus sp from 
Ugandan rain forests increased total and differential WBC counts in cyclophosphamide 
immunosuppressed Wistar rats.  
 
Figure 10. Effect of Corpet on Neutrophil Cell Count in Percentage. 
The total white blood cell count is a tool to identify potential immune response to a 
parasitic challenge and parasite resistance (Kaplan et al, 2004). White Blood cell differential 
count normal value for goats in percentage are 34% neutrophils, 53 % lymphocytes, 1% 
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basophils, 5 % monocytes and 5% eosinophils (khan and Line, 2010). Observed differential cell 
count on the effect of Corpet treatment is shown in Table 2. 
Table 2. 
White blood differential cell count in percentage Averages (%) of Treatment Groups. 
Week  Neutrophil  lymphocytes Eosinophils Basophils  Monocytes 
0 31 67 1 1 0 
4 33 64 1 2 0 
8 36 62 1 1 0 
 
 A differential white blood cell count is an important tool used to provide clinical 
diagnosis, monitoring of disease and blood disorders (Houwen, 2001). This system quantifies 
and differentiates white blood cells at one particular time giving insight to infection and if 
treatments are working (Houwen, 2001). 
4.8 Protein Concentration 
 There was a significant difference between treatments and control (p<0.0001). Over time 
there was an increase plasma protein concentration (p<0.001) for the first four weeks and a 
decrease in the last four weeks (p<0.0001). As observed during week 2 to 5, treatment had a high 
protein concentration compared to control (Fig 11). There was a positive correlation between 
plasma protein concentration and neutrophil cell count (r=0.30, p=0.0013). However, a 
significant negative correlation was observed between protein concentration and coccidia (r=-
0.26, p=0.0073). The reduction in hematological parameters such as changes in plasma protein is 
common clinical symptom of gastrointestinal parasitism.  Immunomodulation by probiotics may 
stimulate increase in plasma proteins (Johnson et al., 2009). 
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Figure 11. Effect of CorPet mushroom extracts on plasma protein concentration in ng/µl. 
4.9 Plasma Protein Migration Pattern on SDS PAGE Gels 
 The SDS gel electrophoresis showed high band intensity among treatments. There was 
difference between treatment and control for week 0, 4 and 8. Protein bands were all the same 
across treatments (Fig. 12). Over time the density of bands observed increases and may be an 
indicator of the observed effect of CV on plasma protein concentration. Thus CV did not have 
adverse effect on cell proteins and white blood cell count. 
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Figure 12. SDS Gel Electrophoresis. PM=marker, C1=control week 1, CO1=cold week1, H1= 
hot week 1, C4 control week 4, CO4=cold week 4, H4=hot week 4, C8=control week 8, CO8= 
cold week 8 and H=hot week 8. 
4.10 Secretion of Proinflammatory Cytokines in Plasma 
The release of proinflammatory cytokines is essential for host survival from infection, 
and is also required for the repair of tissue injury. Proinflammatory cytokine levels were 
measured in plasma from the treatment and control groups at week 0, 4 and 8 of the study. 
Comparing the production of Eight (8) proinflammatory cytokines, the CV extract induced 
detectable levels four (4) cytokines. TNF-α, IL-1a and IL-8 were not detected, IFNr, Rantes and 
GCSF increased while GM-CSF levels decreased from weeks 0 to 8. Lim (2011) reported that 
antiinflammatory response upon treatment with CV extract correlated with the reduced 
expression of TNF-α, IL-1β and IL-6 which corresponds to the low secretion of TNF-α obtained 
in this study. Yu et al (2009) also reported a decrease in levels of serum mucosal interleukin-2 
(IL-2) and TNF-α in rat with oral ulceration of Lentinus edodes. Also Johnson et al., (2009) 
reported that In vivo study of Agaricus blazei reduced the levels of TNF-α by 84% and IL-2 by 
46%.  Batbayar et al., (2011) reported that β-glucan of Ganoderma lucidum induced the sereetion 
P C C0 H C CO H C CO H
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of granulocyte colony-stimulating factor and regulated on activation, normal T expressed and 
secreted (RANTES) which correlates with results obtained in this study. 
   
 
Figure 13. Effect of CorPet on the Secretion of Cytokines. 
The immunomodulatory effects of mushroom are usually associated with the stimulation 
of the immune system by a variety of polysaccharides (Jedinak et al., 2011). β-glucan activates 
B-lymphocytes and macrophages through Toll-like receptors, modulating the immune system 
and inducing the production of cytokines (Liao et al., 2004). The antioxidant activity of Coriolus 
versicolor and the limited adsorption of its PSP and PSK across the intestinal mucosa to the 
blood have been reported. However in this study treatment with CV extracts by drenching 
stimulated cytokine secretion in different manner over time. GCSF and GMCSF may be 
associated with the release of granulocytes and mononuclear cells and associated with the 
observed increases in white blood differential counts for neutrophils and lymphocytes. 
Coriolus versicolor has been reported to improve survival and immune function (in vivo) 
(Amberg et al., 2010). Infections with Eimeria have been observed to result in differential 
cytokine gene expression of IL-10 (Rothwell et al., 2004) and IL-8 in cattle (Coussens, 2004). In 
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this present study these cytokines were not secreted. Chang et al., (2009) reported that oral 
administration of Enoki mushroom displayed anti-tumor activity through activating both innate 
and adaptive immunity of the host to prime a cytotoxic immune response and IFN-γ played a key 
role in the anti-tumor efficacy. Seong et al., (2010) reported that when cells were stimulated with 
β-glucan the macrophage cells increased TNF-α expression, but in our study there was no 
secretion of TNF-α.  
4.11 Secretion of Prostaglandin E2α 
 PGE2α is an inflammatory mediator that secreted by various cells. In this study, over time 
there was a decrease of PGE2α  secretion from week 1 to week 8. Results in this study correlates 
with the study done by Jedinak et al., (2011) which reported that concentrate of oyster mushroom 
inhibited production of prostaglandin E2 through the down regulation of expression of COX-2. 
  
 
Figure 14. Effect of CorPet on the secretion of PGE2α. 
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4.12 RNA Concentration  
There was no statistical significance between treatment and control (p<0.42). There was 
an observable trend of a decrease in RNA concentration in samples from treated goats compared 
to controls for the first 3 weeks and an increase in weeks 4 to 7 (Fig. 15). There was a time effect 
(p<0.001). Treatment increased RNA concentration in weeks 4 to 6. 
 
Figure 15. Effect of CorPet on RNA Concentration from whole Blood in PaXgene Tubes. 
4.13 Effect of CorPet on Gene Expression 
Innate immunity can be stimulated by the activation of pattern recognition receptors. At 
the beginning of the study the number of neutrophil genes detected in the Human Toll-like 
Receptor RT-PCR (Qiagen, Valencia, CA) array was similar for animals in the treatment groups 
(Table 3) (See gene list Appendix). Data was analyzed by subtracting the C(t) value from 
GAPDH. Also data was analyzed by using the C(t) values for each group as a control week 1. 
After 8 weeks, there was an effect of treatment on the regulation of genes. Thirty-seven (37) 
genes were up regulated and forty-seven (47) genes were down regulated for the hot treatment. 
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Twenty-eight (28) genes were up regulated, fifty-six (56) genes were unchanged for the cold 
treatment. 
Table 3. 
Number of Genes Expressed after 8 weeks. 
 Control Hot  Cold 
Higher  38 26 21 
Equal  20 11 10 
Lower  26 47 53 
 
These genes function as receptors, in signaling, adaptors and effectors of the toll-like 
receptor pathway. TAB1 and TIRAP (Appendix) had the highest fold change. At week 1 all Toll-
like receptors except TLR3 and TLR7 were expressed. At week 8 TLR2 was unchanged and 
TLR7 was upregulated. Neutrophils express the majority of TLR family members, lacking only 
the intracellular receptors TLR3 and TLR7 (Prince et al., 2011) which correlates with the result 
obtained from this study.  Ten Toll like receptors have been identified in goats and expression 
has been reported in different tissue (Tirumurugaan et al., 2010), however there are no reports in 
goat neutrophils. Bovine neutrophil have been reported to express TLR (Worku et al., 2009). The 
TLR1 family (TLR1, 2, 6 and 10) is involved in the recognition of gram-positive and gram-
negative bacteria and heterodimers of TLR1 or TLR6 with TLR2 are crucial for the identification 
of several PAMPs (Kwong et al., 2011). TLRs recognize conserved pathogen-associated 
molecular patterns that are unique to microorganisms and are absent from higher eukaryotes 
(Han et al., 2003). Batbayar et al., (2011) reported that expression of TLR2, TLR4 and TLR6 
was increased by β-glucan from Ganoderma lucidum. TLR2 signaling and TLR4 signaling 
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additionally require the bridging adapter Toll-interleukin- 1 receptor (TIR) domain containing 
adapter protein (TIRAP)/MyD88-adapter like (Mal) to link the receptors (Prince et al., 2011). 
The critical role of TIRAP in host defense against Escherichia coli has been reported (Jeyaseelan 
et al., 2005). This result correlates with our study. 
 Gene expression was analyzed for week 0 and week 8 (Table 4) was analyzed using the 
Livak method to determine the effect of treatment. 
Table 4  
Gene Expression for first week and week 8 
 Week 1  Week 8  
 Hot  Cold  Hot Cold 
Up regulated 54 13 75 40 
Unchanged  26 56 8 44 
Down regulated 4 15 0 0 
 
There was an increase in fold change for the hot treatment group for IL2, IL6, IL8, 
ECSIT, TAB1, TLR10 and TLR4 (Fig. 16). Mushroom supplementation increased intracellular 
interleukin (IL)-6 levels suggesting an enhancement of both innate and T cell-mediated 
immunity which leads to a more efficient surveillance and defense mechanism against microbial 
invasion (Ren et al., 2008b).  
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Figure 16. Expression change for a selected set of genes across all of the tested groups for week 
1.Group1=Hot treatment, Group 2=Cold Treatment. 
There was a decrease in fold change for CCL2 and TNF in the hot treatment. For the cold 
treatment group there was an increase in fold change for CCL2, IL8, TAB1, ECSIT, TLR4 and a 
decrease in IL2, IL6, TLR10 and TNF (Fig. 17).  
 
Figure 17. Expression change for a selected set of genes across all of the tested groups for week 
1. Group1=Hot treatment, Group 2=Cold Treatment. 
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The decrease in fold change for TNF could correlate with the lack of secretion of TNF in 
the detection of cytokines. The fold change for TLR4, IL8, TAB1 and ECSIT was increased in 
both the hot and cold treatments. It has being reported that components of Coriolus versicolor 
stimulate T cell activation, induce IFN-γ and IL-2 production, reduce gene expression of 
cytokines (TNF-α, IL-1, IL-6, IL-8) (Cui et al., 2003) which is concordance with the lack of 
secretion of TNF-, IL-1a and IP-10 in plasma.  Response to bacterial- and fungal-specific cell 
wall components through these receptors can be responsible for the initiation of not only the 
inflammatory response but also may direct the adaptive response through activation of specific T 
cells such as Th1, Th2 and T regulatory cell subsets (Price et al., 2010). 
Thus in our study on goat neutrophils the administration of a probiotic containing CV 
modulated toll like receptors and molecules involved in downstream signaling. In light of the 
critical role of TLR in controlling bacterial infections the expression and modulation of these 
genes may be critical to goat health and modulation of innate immunity using mushroom based 
probiotics. The expression of 8 TLRs in goat neutrophils has implications to innate immunity in 
goat and efforts to modulate it through novel therapeutics. 
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10 CHAPTER 5 
Conclusion and Future Research 
Mushrooms and mushroom components have been reported to have a myriad of positive 
health benefits, mainly on the basis of in vitro and in vivo animal trials (Roupas et al., 2012). 
Although there has been relatively few direct intervention trials of mushroom consumption in 
animals, those that have been completed to date indicate that mushrooms and their extracts are 
generally well-tolerated. The results of this study show that mushroom extracts of Coriolus 
versicolor did not reduce gastrointestinal parasites in goats. The probiotics extracts of CV did not 
have an adverse effect on goat health and production. CV Extracts had an impact on protein 
concentration, cytokine levels and RNA. CV probiotics had an impact on gene expression 
targeting the toll-like pathway associated with innate immunity. 
This study has identified gene and proteins that are responsive to mushroom 
supplementation and may serve as targets for future interventions to enhance goat immunity. 
Further studies using more samples are needed to assess the impact on microbial diversity, feed 
efficiency and on global gene expression.  
11  
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Appendix A 
Reagents  
1. Acid Citrate Dextrose 
For 500 ml 
22 g Trisodium citrate (Amhydrous) 
8 g Citric acid 
25 g Dextrose 
 
Bring up to 500 mls with sterile water 
Autoclave and store at 40C 
 
2. DEPC-Treated Water 
1 ml of DEPC was added to 1 liter of distilled water, mixed vigorously and let stand 
overnight  
Then autoclave 
 
3. 2.7% Saline 
27 g NaCl 
Bring volume up to 1 liter with DEPC  
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PCR Components Mix 
2X RT2 SYBR Green Mastermix 1350 µl 
cDNA  102 µl 
RNase-free water 1248 µl 
Total volume 2700 µl 
 
 
PCR Thermal Cycling conditions 
Cycles Duration Temperature 
1 10 minutes 950C 
40 15 seconds 950C 
 1 minute 600C 
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Appendix B 
15 Source: Pierce BCA Handbook 
Preparation of Diluted Albumin (BSA) Standards  
Dilution Scheme for Standard Test Tube Protocol and Microplate Procedure (Working 
Range = 20–2,000 µg/ml)  
Vial  Volume of Diluent  Volume and Source of BSA   Final BSA Concentration  
A  0    300 µl of Stock    2,000 µg/ml  
B  125 µl    375 µl of Stock    1,500 µg/ml  
C  325 µl    325 µl of Stock    1,000 µg/ml  
D  175 µl    175 µl of vial B dilution   750 µg/ml  
E  325 µl    325 µl of vial C dilution   500 µg/ml  
F  325 µl    325 µl of vial E dilution   250 µg/ml  
G  325 µl    325 µl of vial F dilution   125 µg/ml  
H  400 µl    100 µl of vial G dilution   25 µg/ml  
I  400 µl    0      0 µg/ml = Blank 
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Appendix C 
16 Source: Signosis Human Inflammation ELISA Strip Protein Standards Handbook 
Reagent Preparation  
Dilute the 5x Assay wash buffer to 1x buffer  
40ml 5x Assay wash buffer  
160ml ddH2O 
Use serum-free conditioned media or original or 10-fold diluted sera.  
Sera can be diluted with 1X 
Diluent buffer. When serum-containing conditioned media is required, be sure to use serum as a 
control. 
Dilute 50 times of biotin labeled antibody mixture with 1X Diluent buffer. 
Dilute 200 times of streptavidin-HRP with 1X Diluent buffer. 
Assay procedure  
1. Cut the sealing film over the plate and remove it from the desired number of well strips. Make 
sure the rest of wells are well sealed.  
2. Add 100 µl of Standard, control, or sample per well and incubate for 1 hour at room 
temperature with gentle shaking.  
3. Aspirate each well and wash by adding 200µl of 1X Assay wash buffer. Repeat the process 
three times for a total of three washes. Complete removal of liquid at each wash. After the last 
wash, remove any remaining liquid by inverting the plate against clean paper towels.  
4. Add 100µl of diluted biotin-labeled antibody mixture to each well and incubate for 1 hour at 
room temperature with gentle shaking.  
5. Repeat the aspiration/wash as in step 3.  
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6. Add 100 µl of diluted streptavidin-HRP conjugate to each well and incubate for 45 min at 
room temperature with gentle shaking.  
7. Repeat the aspiration/wash as in step 3.  
8. Add 100µl substrate to each well and incubate for 10- 30 minutes.  
9. Add 50µl of Stop solution to each well. The color in the wells should change from blue to 
yellow.  
10. Determine the optical density of each well with a microplate reader at 450 nm within 30 
minutes. 
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Appendix D 
17 Source: Bio-Rad, DCode Universal Detection System Handbook 
Tsai and Frasch Silver Stain 
Materials and Equipment needed:  
• Orbital Shaker  
• Staining tray  
• Ethanol Acetic Acid  
• Periodic acid  
• Silver nitrate NaOH  
• Citric acid  
• Formaldehyde  
• DH2O  
1. Use Powder-free gloves throughout the silver staining procedure.  
2. Transfer gels from gel cassettes into staining trays filled with fixative (1).  
3. Place on a shaker overnight to fix the samples. Perform all steps at room temperature.  
4. After the overnight fixing step, discard the fixative and add the oxidizer solution (2). Make 
fresh daily. Place the gel on the shaker for 5 minutes.  
5. Wash the gel in DH2O for 15 minutes. Repeat this step twice.  
6. Incubate the gel 30 minutes in silver stain solution (3). Prepare fresh and follow with three 10 
minute washes.  
7. Develop the gel in developer solution.  
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Solutions  
1) Fixative  
Ethanol   400 ml  
Acetic acid   50 ml  
DH2O   550 ml  
2) Oxidizer (Prepare fresh daily)  
Solution (1)   100 ml  
Periodic acid   0.7 g 
3) Silver Stain (Prepare fresh daily)  
DH 2 O   115 ml  
NaOH    (0.4 g/ 100ml DH 2O) 28.0 ml  
*AgNO3  (1 g/5ml) 5.0 ml  
*Conc NH4OH  2.0 ml  
*Add last and simultaneously  
4) Developer  
Citric acid   50 mg  
37% Formaldehyde  0.5 ml  
DH2O   1 liter   
5) Stop Solution (10% Acetic acid)  
Acidic acid   100 ml  
DH2O   900 ml 
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Appendix E 
18 Source: Qiagen Human Toll-like Receptor pathway handbook 
Symbol Description 
BTK Bruton agammaglobulinemia tyrosine kinase 
CASP8 Caspase 8, apoptosis-related cysteine peptidase 
CCL2 Chemokine (C-C motif) ligand 2 
CD14 CD14 molecule 
CD80 CD80 molecule 
CD86 CD86 molecule 
CHUK Conserved helix-loop-helix ubiquitous kinase 
CLEC4E C-type lectin domain family 4, member E 
CSF2 Colony stimulating factor 2 (granulocyte-macrophage) 
CSF3 Colony stimulating factor 3 (granulocyte) 
CXCL10 Chemokine (C-X-C motif) ligand 10 
EIF2AK2 Eukaryotic translation initiation factor 2-alpha kinase 2 
ELK1 ELK1, member of ETS oncogene family 
FADD Fas (TNFRSF6)-associated via death domain 
FOS FBJ murine osteosarcoma viral oncogene homolog 
HMGB1 High mobility group box 1 
HRAS V-Ha-ras Harvey rat sarcoma viral oncogene homolog 
HSPA1A Heat shock 70kDa protein 1A 
HSPD1 Heat shock 60kDa protein 1 (chaperonin) 
IFNA1 Interferon, alpha 1 
IFNB1 Interferon, beta 1, fibroblast 
IFNG Interferon, gamma 
IKBKB 
Inhibitor of kappa light polypeptide gene enhancer 
 in B-cells, kinase beta 
IL10 Interleukin 10 
IL12A 
Interleukin 12A (natural killer cell stimulatory 
 factor 1, cytotoxic lymphocyte maturation factor 1, p35) 
IL1A Interleukin 1, alpha 
IL1B Interleukin 1, beta 
IL2 Interleukin 2 
IL6 Interleukin 6 (interferon, beta 2) 
IL8 Interleukin 8 
IRAK1 Interleukin-1 receptor-associated kinase 1 
IRAK2 Interleukin-1 receptor-associated kinase 2 
IRF1 Interferon regulatory factor 1 
IRF3 Interferon regulatory factor 3 
JUN Jun proto-oncogene 
LTA Lymphotoxin alpha (TNF superfamily, member 1) 
CD180 CD180 molecule 
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LY86 Lymphocyte antigen 86 
LY96 Lymphocyte antigen 96 
MAP2K3 Mitogen-activated protein kinase kinase 3 
MAP2K4 Mitogen-activated protein kinase kinase 4 
MAP3K1 Mitogen-activated protein kinase kinase kinase 1 
MAP3K7 Mitogen-activated protein kinase kinase kinase 7 
TAB1 TGF-beta activated kinase 1/MAP3K7 binding protein 1 
MAP4K4 Mitogen-activated protein kinase kinase kinase kinase 4 
MAPK8 Mitogen-activated protein kinase 8 
MAPK8IP3 Mitogen-activated protein kinase 8 interacting protein 3 
MYD88 
Myeloid differentiation primary response gene (88) 
 
NFKB1 
Nuclear factor of kappa light polypeptide gene  
enhancer in B-cells 1 
NFKB2 
Nuclear factor of kappa light polypeptide gene  
enhancer in B-cells 2 (p49/p100) 
NFKBIA 
Nuclear factor of kappa light polypeptide gene  
enhancer in B-cells inhibitor, alpha 
NFKBIL1 
Nuclear factor of kappa light polypeptide gene  
enhancer in B-cells inhibitor-like 1 
NFRKB Nuclear factor related to kappaB binding protein 
NR2C2 Nuclear receptor subfamily 2, group C, member 2 
PELI1 Pellino homolog 1 (Drosophila) 
PPARA Peroxisome proliferator-activated receptor alpha 
PRKRA 
Protein kinase, interferon-inducible double  
stranded RNA dependent activator 
PTGS2 
Prostaglandin-endoperoxide synthase 2  
(prostaglandin G/H synthase and cyclooxygenase) 
REL V-rel reticuloendotheliosis viral oncogene homolog (avian) 
RELA 
V-rel reticuloendotheliosis viral oncogene  
homolog A (avian) 
RIPK2 Receptor-interacting serine-threonine kinase 2 
SARM1 Sterile alpha and TIR motif containing 1 
SIGIRR 
Single immunoglobulin and toll-interleukin 1  
receptor (TIR) domain 
ECSIT ECSIT homolog (Drosophila) 
TBK1 TANK-binding kinase 1 
TICAM2 Toll-like receptor adaptor molecule 2 
TIRAP 
Toll-interleukin 1 receptor (TIR) domain containing  
adaptor protein 
TLR1 Toll-like receptor 1 
TLR10 Toll-like receptor 10 
TLR2 Toll-like receptor 2 
TLR3 Toll-like receptor 3 
TLR4 Toll-like receptor 4 
TLR5 Toll-like receptor 5 
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TLR6 Toll-like receptor 6 
TLR7 Toll-like receptor 7 
TLR8 Toll-like receptor 8 
TLR9 Toll-like receptor 9 
TNF Tumor necrosis factor 
TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A 
TOLLIP Toll interacting protein 
TRAF6 TNF receptor-associated factor 6 
TICAM1 Toll-like receptor adaptor molecule 1 
UBE2N Ubiquitin-conjugating enzyme E2N 
UBE2V1 Ubiquitin-conjugating enzyme E2 variant 1 
B2M Beta-2-microglobulin 
HPRT1 Hypoxanthine phosphoribosyltransferase 1 
RPL13A Ribosomal protein L13a 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
ACTB Actin, beta 
HGDC Human Genomic DNA Contamination 
RTC Reverse Transcription Control 
RTC Reverse Transcription Control 
RTC Reverse Transcription Control 
PPC Positive PCR Control 
PPC Positive PCR Control 
PPC Positive PCR Control 
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Appendix F 
The scatter plot compares the normalized expression of every gene on the array between two 
groups by plotting them against one another to quickly visualize large gene expression changes. 
The central line indicates unchanged gene expression.  
 
Figure 18. Scatter plot showing number of up regulated genes (red), down regulated genes 
(green) and unchanged genes (black) for hot treatment week 0. 
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Figure 19. Scatter plot showing number of up regulated genes (red), down regulated genes 
(green) and unchanged genes (black) for cold treatment week 0. 
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Figure 20. Scatter plot showing number of up regulated genes (red), down regulated genes 
(green) and unchanged genes (black) for hot treatment week 8. 
.  
Figure 16. Scatter plot showing number of up regulated genes (red), down regulated 
genes (green) and unchanged genes (black) for cold treatment week 8. 
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Appendix G 
Table 3. 
Summary of Effect of Treatments 
 Hot  Cold  
FAMACHA - - 
Body Weight - - 
Body Condition - - 
Fecal Egg Count - - 
PCV - - 
White Blood Cell Differential - - 
RNA Concentration - - 
Plasma Protein Concentration + + 
Cytokines + + 
Gene Regulation 
                  Up Regulation 
                  Down Regulation 
                  Unchanged 
 
75 
8 
0 
 
40 
44 
0 
-no effect, + effect 
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Appendix H 
19 Source: Cayman ELISA Handbook 
Addition of  EIA Buffer to wells 
One Hundred (100) μl of EIA Buffer was added to NSB wells. Fifty (50) μl of EIA 
Buffer was also added to the B0 wells 
Addition of Prostaglandin E2 EIA Standards to wells 
  Fifty (50) μl from tube #8 was added to both of the lowest standard wells (S8). Fifty (50) 
μl from tube #7 was also added to each of the next two standard wells (S7). The procedure was 
continued until all the standards were aliquoted. The same pipette tip should was used to aliquot 
all the standards 
Addition of Samples to wells 
Fifty (50) μl of sample was added per well. Each sample should be assayed was assayed 
in triplicates 
Addition of Prostaglandin E2 AChE Tracer 
Fifty (50) μl of AChE Tracer was added to each well except the TA and the Blk wells. 
 Addition of Prostaglandin E2 Monoclonal Antibody 
Fifty (50) μl was added to each well except the TA, the NSB, and the Blk wells 
Incubation of plate 
The plate was covered with a plastic film and incubated over night at 4°C. 
Development of the Plate 
Wells were emptied and rinsed five times with Wash Buffer. Two hundred (200) μl of 
Ellman’s Reagent was added to each well. Five (5) μl of tracer was added to the TA well. The 
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plate was covered with plastic film and placed on an orbital shaker equipped with a large, flat 
cover for 90 minutes to develop in the dark.  
Reading the Plate 
The bottom of the plate was wiped with a clean tissue to remove fingerprints, dirt, etc. 
The plate cover was removed. The plate was inserted into a micro plate reader (BioTek) read at 
wavelengths 405, 410, 415, 417 and 420 nm.  
Standard Curve 
SAS was used to plot %B/B0 for standards S1-S8 versus PGE2 concentration using a 
logit transformation.  
 
 
 
 
 
 
 
 
 
 
